💹 Your Post-Notable Earnings Report (Jan 10)

Open Email...Your Morning Report Inside…Post Earnings for Major Stocks

Unsubscribe Little known biotech firm is revolutionizing antiviral treatment to fight several deadly diseases. (ad)* Dear Reader, I hope you are having a great Friday and also hope you have a good weekend ahead of you! I am sending you the list of major stocks which reported Earnings a few days ago with Earnings Surprise (to help you find Post-Earnings trading and/or investing opportunities). This public company's one lead drug alone, NV-387, potentially addresses a $2.5 to $4.3 billion market (ad)* Imagine a drug that could treat VIRUSES— such as RSV, COVID-19, Influenza, Bird Flu, Monkey Pox, and more. We might not have to imagine it much longer. This company's leading drug candidate could completely transform how viruses and their variants are treated worldwide. NV-387 could revolutionize antiviral treatment just as antibiotics did against bacteria. Learn more about the company that could largely benefit your bottom line, as well as the health of our global population. Symbol Company Earning Date EPS Surprise % AVXL 12/23 17.65% CCL 12/20 75.00% FCEL 12/19 -28.05% BB 12/19 133.33% ACN 12/19 6.21% FDX 12/19 3.85% CAG 12/19 2.94% NKE 12/19 23.81% LEN 12/18 -3.12% MU 12/18 1.25% CIEN 12/12 -30.43% COST 12/12 0.79% RH 12/12 -7.12% AVGO 12/12 10.62% M 12/11 -42.86% Click Here to View Your Full Report Before Market Open After Market Close This Growing Biotech Firm is Fighting Viruses in a Unique Way (ad)* Biotech company has a potentially revolutionary antiviral drug where viruses are unlikely to escape! With plenty of cash on hand, discover how this small-cap biotech firm is revolutionizing antiviral therapy and building shareholder value. This small cap biotech stock has major catalysts on the horizon (ad)* NYSE-traded biotech firm has a revolutionary offering to the medical world since antibiotics! Click here for the name and ticker symbol How to use EPS Surprice in your Post-Earnings trading strategies: Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's earnings announcement) or the Price Reversal strategy (to target the reversal of next-day big price movement). Please click on Ride-the-Wave Strategy to learn more about it. Stock Trading - If you're a stock trader/investor or portfolio manager, you may want to consider adjusting your positiosn based on a EPS surprise reported by the company. At Daily Options Signals, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader. To your trading success, Support Team Daily Options Signals PS: Daily Options Signals is morning newsletter, powered by StockEarnings proprietary technology. Daily Options Signals SMS is Here!  Join SMS Text and never miss any stock trade alerts or special offers from Daily Options Signals and our advertising partners ever again... Click right here to join Daily Options Signals SMS List

(ad)* This message is a PAID ADVERTISEMENT for NanoViricides, Inc. (NYSE American: NNVC) from Interactive Offers. StockEarnings, Inc. has received a fixed fee of $4,500 for multiple Dedicated Email Sends, Newsletter Sponsorship, and SMS sends between January 10, 2024 and January 16, 2024. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either NanoViricides, Inc. (NYSE American: NNVC) or Interactive Offers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding NanoViricides, Inc. (NYSE American: NNVC) on Smallcaps Daily website for additional information about the relationship between Interactive Offers and NanoViricides, Inc. (NYSE American: NNVC). Daily Options Signals is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers. StockEarnings Inc. 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | W: 877.6.STOCKS Unsubscribe Today's Bonus Content: Ready to Find the Next 3,000% Surge? (By clicking this link, you are subscribing to receive messages from Fierce Investor)